159 related articles for article (PubMed ID: 17075490)
1. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
2. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Marcellin P; Lada O
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
[No Abstract] [Full Text] [Related]
3. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Bourlière M
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
[No Abstract] [Full Text] [Related]
4. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
Zarski JP
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
[No Abstract] [Full Text] [Related]
5. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
6. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
Kaplan DD; Reddy KR
Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
[No Abstract] [Full Text] [Related]
7. Chronic hepatitis B: back to the future with HBsAg.
Moucari R; Lada O; Marcellin P
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
[No Abstract] [Full Text] [Related]
8. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Zoulim F
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
[No Abstract] [Full Text] [Related]
9. Antiviral therapy of chronic hepatitis B.
Zoulim F
Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
[TBL] [Abstract][Full Text] [Related]
10. [Clinical consequences of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Cadranel JF
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S12-6. PubMed ID: 17075489
[No Abstract] [Full Text] [Related]
11. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
12. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
13. [Are phyllanthus species effective in hepatitis B?].
Rakowitz B
Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1460. PubMed ID: 21732258
[No Abstract] [Full Text] [Related]
14. Chronic hepatitis B: who to treat and which choice of treatment?
Di Marco V; Craxì A
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance after lamivudine therapy for chronic hepatitis B.
Sarrecchia C; Volpi A; Sordillo P; Andreoni M
Int J Infect Dis; 2009 May; 13(3):e133-4. PubMed ID: 18990599
[No Abstract] [Full Text] [Related]
16. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
Mauss S; Wedemeyer H
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the treatment recommendations for chronic hepatitis B.
Chan HL
Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
[No Abstract] [Full Text] [Related]
18. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
19. Entecavir surprise.
Hirsch MS
N Engl J Med; 2007 Jun; 356(25):2641-3. PubMed ID: 17582076
[No Abstract] [Full Text] [Related]
20. Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
Fukai K; Zhang KY; Imazeki F; Kurihara T; Mikata R; Yokosuka O
J Viral Hepat; 2007 Sep; 14(9):661-6. PubMed ID: 17697019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
